Jan 28, 2020 / 02:30PM GMT
Operator
Good day, and welcome to the Sartorius and Sartorius Stedim Biotech Conference Call on the Preliminary Full Year 2019 Results. Today's conference is being recorded. At this time, I would like to turn the conference over to Dr. Joachim Kreuzburg, CEO. Please go ahead, sir.
Joachim Kreuzburg - Sartorius Aktiengesellschaft - Chairman of Executive Board & CEO
Thank you very much, and welcome, everybody, to our -- today's call on the financial results for 2019, the preliminary results, I should say, and also the guidance for the year 2020 for both the Sartorius Group as well as for Sartorius Stedim Biotech.
I would like to kick off today's call by talking a little bit about the main highlights of financial 2019, and then I will hand over to Rainer Lehmann, our CFO.
So the highlights last year clearly have been, first of all, that growth on all levels, sales revenues, order intake as well as profit has been in the double-digit area, particularly our Bioprocess Solutions, again, has grown very nicely with a very strong momentum throughout the
Preliminary Q4 2019 Sartorius AG Earnings Call Transcript
Feb 14, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers